NCT07005986View on ClinicalTrials.gov

Role of Circulating Pyrophosphate as a Biomarker of Mediacalcinosis in Type 2 Diabetic Patients

NARecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

June 18, 2025

Primary Completion Date

July 18, 2026

Study Completion Date

July 18, 2026

Conditions

Type 2 DiabetesType 2 Diabetes Patients

Interventions

DIAGNOSTIC_TEST

Plasmatic PPi level

Plasmatic PPi level dosage at visit 1

Trial Locations (1)

06000

RECRUITING

CHU de Nice, Nice

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nice

OTHER